Sage Journals: Discover world-class research

Abstract

available at http://jama.ama-assn.org/cgi/ content/full/297/11/1197

Keywords

peripheral arterial disease risk reduction coronary artery disease atherosclerosis

Get full access to this article

View all access options for this article.

References

Bhatt DL , Steg PG , Ohman EM , et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189.

Criqui MH , Langer RD , Fronek A. , et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.

Jelnes R. , Gaardsting O. , Hougaard Jensen K , Baekgaard N. , Tonnesen KH , Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed). 1986;293:1137-1140.

Golomb BA , Dang TT , Criqui MH Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114:688-699.

Smith SC Jr. , Allen J. , Blair SN , et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363-2372.

One-year cardiovascular event rates in outpatients with atherothrombosis. Steg PG,Bhatt DL,Wilson PW,et al;REACH Registry Investigators. JAMA. 2007;297: 1197-1206

Abstract

Keywords

Get full access to this article

References